Submitted by Jess May on

Welcome to the Allied Health Virtual Journal Club. For each journal club, a high yield article (or two) will be selected and various questions about the article will be presented. After reading the article, please post your own questions or discussion points for others to reply. The purpose is to create a discussion forum for our Allied Health Community. A link to the article will be provided, but let us know if you have any difficulties obtaining the article.

Articles:

Du Toit, G. et. al., Randomized Trial of Peanut Consumption in Infants at Risk for Peanut Allergy. The New England Journal of Medicine, Volume 372 No. 9. 2015. Massachusetts Medical Society.
https://pubmed.ncbi.nlm.nih.gov/25705822/

Jones, S., et. al., Efficacy and Safety of Oral Immunotherapy in Children Aged 1-3 Years with Peanut Allergy (the Immune Tolerance Network IMPACT Trial): A Randomized Placebo-Controlled Study. 2022. Lancet.
https://pubmed.ncbi.nlm.nih.gov/35065784/

Objectives:

  1. Explain the clinical implications from the results of the LEAP and IMPACT studies
  2. Identify the research gaps and limitations of the data from the LEAP and IMPACT studies